There was a great deal of interest amongst the veterinarians and many of them stopped at HIPRA’s stand to find out the details of the combination.
In addition, Joel Miranda, PRRS Brand Manager, gave a presentation during the convention entitled “Safety and efficacy of the combined use of UNISTRAIN® PRRS and AUSKIPRA® GN by ID and IM routes” in which he spoke of the importance of the combination of vaccines on the farm and presented the technical results of the combination.
This new landmark means that HIPRA is the first global pharmaceutical company to achieve the registration of this combination, thereby reaffirming the company’s commitment to continuing to provide practical and effective solutions for health control in swine production.
